Sign in
Latest News
Pharmaceuticals
BioPharma
MedTech
B2B News
Healthcare
Health Insurance
Nutrition & Wellness
Agro-Pharma
Animal Health
Regulations
Industry Reports
Reviews
About Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Wednesday, February 5, 2025
Sign in / Join
Latest News
Pharmaceuticals
BioPharma
MedTech
B2B News
Healthcare
Health Insurance
Nutrition & Wellness
Agro-Pharma
Animal Health
Regulations
Industry Reports
Reviews
About Us
Facebook
Instagram
Twitter
Vimeo
Youtube
Latest News
Pharmaceuticals
BioPharma
MedTech
B2B News
Healthcare
Health Insurance
Nutrition & Wellness
Agro-Pharma
Animal Health
Regulations
Industry Reports
Reviews
About Us
Search
LATEST ARTICLES
Italy Opens Antitrust Case Against Novartis, Roche, and Others
0
AbbVie’s Achieves Trial Success in Ovarian Cancer Subtype
0
Jury Orders to J&J to Pay $260m in Latest Talc Trial
0
Novo Nordisk Launches Campaign for Injectable Weight-Loss Drug Wegovy
0
FDA Raises No Major Concerns About Eli Lilly’s Alzheimer’s Drug
0
AbbVie advances oncology pipeline with Phase 3 ABBV-383 trial
0
Novo Nordisk Prepares for China’s Weight-Loss Drug Market
0
Summit Therapeutics & AstraZeneca Shine at Major Cancer conference
0
Amgen’s Uplizna Proves Its Worth in Another Rare Disease
0
Eli Lilly & QurAlis Forge New Path with ALS Drug Deal
0
1
...
11
12
13
...
19
Page 12 of 19
Most Popular
Medtronic recall of brain fluid drainage systems linked to 15 injuries
Algiax announces results from phase 2a trial for neuropathic pain treatment
How We Picked Our Winners for the 2025 Health Tech Awards
Grifols collaborates with startup FcR Therapeutics to develop autoimmune therapies
Load more
Recent Comments
AstraZeneca $20Bn Strategy - Pro Pharma News
on
Summit Therapeutics & AstraZeneca Shine at Major Cancer conference
China’s Generic Ozempic - Pro Pharma News
on
Ozempic’s Growing Generic Competition
Recent Comments